Bladder cancer is more aggressive and more advanced in South Texas residents ­than in many parts of the country, a study by the Mays Cancer Center indicates.

UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.

Experts share what is known about COVID-19 vaccines and immunocompromised patients as well as the vaccination plan for cancer patients.

The Mays Cancer Center, home to UT Health San Antonio MD Anderson, joins organizations across the world to honor World Cancer Day on Feb. 4.

The coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, and acting as soon as is safely possible can lead to much better outcomes in the future.

Amelie G. Ramirez, DrPH, MPH, director of Salud America! at UT Health San Antonio and a leading health disparities researcher, has been selected to serve as the 2021-2022 chair of the Women in Cancer Research Council of the American Association for Cancer Research (AACR).

It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. Dr. Sandeep Burma and a team of investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, are studying companion treatments to see if any can eliminate this Jekyll and Hyde property of ionizing radiation.

The newer procedure is called robotic retroperitoneal lymph node dissection, or robotic RPLND. Although the procedure has been previously reported, Mays Cancer Center developed technical improvements to make it safer, more effective and applicable in new indications.

Yoga improved physical and mental well-being and promoted a robust immune response in a randomized clinical trial of men with prostate cancer.

Researchers from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, will present results of multiple lines of study Dec. 7-10 during the 2021 San Antonio Breast Cancer Symposium.